KDR and Hypertension: VEGF inhibitor-induced hypertension: A crucial line of evidence comes from oncology, where drugs targeting the VEGF pathway—such as VEGF inhibitors like bevacizumab or VEGFR inhibitors like sunitinib and pazopanib—are widely used.